One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies

Contributed by: Business Wire

Logo

Tags

Research

Technology

Professional Services

Biotechnology

Data Analytics

Pharmaceutical

Health

Science

Oncology

Artificial Intelligence

One Biosciences

More Like This

Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals

Brenus Pharma Joins the Paris Saclay Cancer Cluster (PSCC) to Collaborate at the Heart of Innovation in Oncology

BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025

Byondis to Present Data from its Novel ADC Technology Platforms at the American Society for Cancer Research Meeting 2026

PR Newswire associated0

OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class CD64-Targeting ADC for Monocytic Leukemia, at the 67th ASH Annual Meeting

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates

PR Newswire associated0

Thousand Oaks Biologics Showcases Integrated ADC CRDMO Solutions & Media Innovation for Industrialization at CPHI Frankfurt 2025